Pick Up This Deal Even Lower Than Chief Financial Officer Bjerkholt Did
September 23, 2019 at 10:04 AM EDT
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on September 18, Aimmune Therapeutics Inc's Chief Financial Officer, Eric Bjerkholt, invested $34,976.68 into 1,550 shares of AIMT, for a cost per share of $22.57..